Biomedical Sciences Blog

The purpose of this Program is to develop and evaluate multidisciplinary career development programs in non-malignant hematology and transfusion medicine that will equip new investigators with the knowledge and skills to address complex problems in blood diseases and transfusion medicine. Through this Program, the NHLBI will support the early career development of clinical researchers who are expected to become independent investigators and assume academic leadership roles in non-malignant clinical hematology and transfusion medicine. To accomplish this, NHLBI invites institutions with established clinical research infrastructures and expertise in non-malignant clinical hematology and transfusion medicine to submit applications to establish Clinical Hematology and Transfusion Medicine Research Career Development Programs. Programs supported under this FOA should provide comprehensive, multidisciplinary training in research designs and methodologies, standard and potentially future or innovative approaches to the clinical management of patients with non-malignant hematologic diseases as well as transfusion practices for multiple patient populations, and research opportunities in these clinical settings. Programs should include a core curriculum, didactics, and a short-term research project for each Scholar.

The official announcement and description of this opportunity may be found on the funding agency's website:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-005.html

• Letter of Intent Due Date: May 20, 2011
• Application Due Date(s): June 20, 2011, by 5:00 PM local time of applicant organization.
  

Award Amount:

Application budgets are limited to $370,000 in direct costs per year. The maximum project period is 5 years.
Numerical value: $1,850,000